APCs, which generates antigen-derived peptides, and analyzing susceptibility to autoimmunity. Human lymphocyte the peptide-binding preferences of available HLA class antigen (HLA) associations are recognized for many autoim-II molecules. The structural basis for class II/peptide mune diseases, but the mechanisms are not clear. Goodpasinteractions is well understood [reviewed in 3], but how
The mechanisms by which inheritance of HLA class been identified. Therefore, it may be possible to directly ana-II alleles influence susceptibility to autoimmune diseases lyze interactions between the antigen and HLA molecules assomay be different, or at least more complex, than those ciated with the disease, and to examine influences on antigen presentation to T cells. Towards this goal, we present a detailed that operate for exogenous antigens [5] . This is because analysis of HLA associations with the disease and examine T-cell responses to self are influenced by self-tolerance molecular mechanisms that could account for them. [6, 7] . T cells with high avidity for class II molecule/ self-peptide complexes are deleted in the thymus during ontogeny, a process called central tolerance. Many po-Most autoimmune diseases have associations with spetentially autoreactive T cells escape thymic deletion eicific alleles inherited at loci encoding human lymphocyte ther because their receptors have low affinity for constiantigen (HLA)-DR, -DQ, and -DP molecules in the class tutively displayed self-peptide/HLA complexes or because II region of the HLA gene complex on chromosome 6 they recognize "cryptic" self-peptides that are not consti- (Fig. 1 ). The reasons for these associations are not known tutively displayed by thymic APCs [8] . These T cells do [1] , but the simplest explanation is that HLA class II not usually cause autoimmune disease because they are alleles influence autoimmune responses in the same way probably controlled by several mechanisms, collectively they determine responses to foreign antigens, that is, by known as peripheral tolerance. Autoimmune disease is encoding HLA class II molecules with distinctive pepthought to follow either a breakdown of peripheral tolertide-binding characteristics that selectively bind and ance or a perturbation of normal self-antigen processing present particular antigen-derived peptides for display and presentation that results in the display to T cells of to CD4-positive T cells [2] , a cell type that is pivotal peptides that are not normally generated, cryptic epiin most cell-mediated and humoral immune responses, topes [9] . including those to self-antigens. CD4-positive T cells rec-Much of the understanding of these processes derives ognize antigens in the form of short peptides bound from the analysis of inbred strains of mice, and there is to HLA class II molecules on the surface of antigena clear need for experimental approaches to study tolerpresenting cells (APCs) such as dendritic cells, macrophages, and B cells. The range of antigen-derived ance in outbred populations such as humans. Goodpaspeptides available for recognition by CD4 T cells is deterture's provides an ideal "model disease" for such studies mined by both the antigen-processing machinery of the for several interrelated reasons. First, the HLA associations with the disease are very striking [10] [11] [12] [13] [14] [15] . Not only is the positive association with HLA DRB1*1501 among ) . DQA, DQB, DPA, and DPB are all polymorphic, although less so than DRB1. The low frequency of recombination events within this region gives rise to substantial linkage disequilibrium. For example, almost all haplotypes carrying DRB1 alleles encoding DR2 molecules occur with a functional DRB5 locus, and they effectively are always inherited with particular DQA and DQB alleles (bottom right). Many of the other genes in the HLA region are known to encode molecules and have important roles in immune responses, and some are also in linkage disequilibrium with DRB1. The inheritance of these or other genes yet to be discovered very likely accounts for some HLA associations, for example, that with narcolepsy.
disease involves relatively few alleles, as this, to some that are known to be generated by natural processing within human APCs, opening a window on the mecha-extent, simplifies the analysis.
Second, the target of autoimmune attack is known to nisms underlying HLA associations with immune responses to particular self-antigens. reside in the 230 amino acid COOH-terminal NC1 domain of the ␣3 chain of type IV collagen [␣3(IV)NC1], Fourth, Goodpasture's disease is a well-defined and consistent disease entity across populations [reviewed in for which cDNA has been cloned and the recombinant expression established [16] [17] [18] [19] . Knowledge of the se-22]. The disease is defined precisely by its immunopathogenesis, namely the presence of autoantibody to the glo-quence of the target antigen and its small size relative to many other autoantigens is an important advantage merular basement membrane, and autoantibodies from all patients not only recognize the same antigen, namely over other autoimmune diseases because it permits direct examination of interactions between relevant class ␣3(IV)NC1, but appear to bind to a single or very few epitopes within ␣3(IV)NC1 [23-26]. This is important II molecules and autoantigen-derived peptides. Such interactions are likely to be key events in the development as it greatly reduces the possibility of confounding effects caused by disease heterogeneity among "patients" in of autoimmune responses.
Third, information is available on the natural pro-studies from multiple centers. Goodpasture's disease therefore provides an excep-cessing and presentation of ␣3(IV)NC1 [20, 21] that is not available for any other autoimmune disease of exper-tional opportunity to examine the relationship between the inheritance of HLA class II alleles and susceptibility imental model of autoimmunity. This makes it possible to consider how class II molecules with different disease to autoimmune renal disease and to autoimmunity in general. The purpose of this review is to describe as fully associations might interact with antigen-derived peptides as possible the associations between HLA alleles and data were suitable for meta-analysis of phenotype fre-Goodpasture's disease and then consider possible mechquencies. Figure 2A shows the odds ratios for the occuranisms for the associations in the light of knowledge of rence of selected DR phenotypes in patients and controls the autoantigen and of the structure and function of the for each individual study, together with the estimated relevant class II molecules. odds ratio calculated from the combined data using a fixed-effects meta-analysis approach. The principal findings were a very strong association with DRB1*1501 HLA CLASS II PHENOTYPE AND (OR 8.5, 95% CI 5.5 to 13.1, P Ͻ 0.0001), a positive ALLELE FREQUENCIES association with DR4 (OR 1.4, 95% CI, 1.0 to 2.1, P ϭ There are four reports comparing HLA class II geno-0.035), and apparent negative associations with DR7, type frequencies in patients with Goodpasture's disease DR1, DR11, and DR13. with appropriate controls ( Table 1) . The largest study, Some of the apparent negative associations could have reported by Fisher et al, compared 82 British Caucasoid been artifacts caused by the very high frequency of patients with a control population of 177 Caucasoids DRB1*1501 and consequent reduction in the frequency resident in the same region of the United Kingdom [15] ; of all other alleles. The high frequency of DR15 could this control population was more fully described by Dohsimilarly have obscured weaker positive associations. erty et al [27] . Dunkley et al compared 36 Australian These problems can be overcome by relative predisposi-Caucasoid patients with 202 Australian Caucasoid contional analysis, a technique shown by Payami et al to trols [12] . Huey et al studied 23 U.S. Caucasoid patients be appropriate for analyzing allele frequencies in the and compared the allele frequencies reported for a large presence of one or a few preponderant alleles [29] . Overpopulation of U.S. Caucasoids in the 11th Histocompatiall, 118 of the 278 patient alleles were DRB1*1501, giving bility Workshop [13, 28] . The smallest study has been a frequency of 0.42, which is about 3.5 times higher than published only in abstract form (abstract; Mercier et al, in the control groups. Analysis after removal of 1501 J Am Soc Nephrol 3:658, 1992). The principal conclusion alleles from patient and control populations ( Fig. 2B ) of the four studies in four different Caucasoid groups was demonstrated a significant increase of the frequencies of that most patients with Goodpasture's disease inherited DR3 (OR ϭ 1.7, 95% CI, 1.1 to 2.5, P ϭ 0.009) and DRB1*1501 ( Table 2) . DR4 (OR ϭ 2.5, 95% CI, 1.7 to 3.5, P Ͻ 0.001) alleles Genotype data on 139 patients of the patients deamong patients, and a decreased frequency of DR7 scribed in the three larger studies have been obtained (OR ϭ 0.3, 95% CI 0.1 to 0.6, P ϭ 0.001) and DR1 from the publications or from the authors. All of these alleles (OR ϭ 0.6, 95% CI 0.3 to 1.0, P ϭ 0.034). Alleles studies used genotyping techniques to define DRB1 and encoding DR11 and DR13, the two other antigens with DQB1 alleles, but none of the studies examined the possible negative associations with Goodpasture's dis-DP alleles. The precision of allele identification varied ease, all occurred at frequencies consistent with their between the studies; for example, the study by Dunkley inheritance having no influence on susceptibility. et al did not distinguish subtypes of DRB1*04 nor many of the recently defined splits of DQB. Nevertheless, the HLA DQB1 alleles were characterized in all of the 139 patients, but only the studies reported by Huey et 2.4, 95% CI, 1.5 to 3.7) and a decreased frequency of DQB1*0501 (OR ϭ 0.5, 95% CI, 0.2 to 1.0). al and Fisher et al distinguished many subtypes. Therefore, the results of all three studies could only be com-In summary, the meta-analysis of allele and phenotype frequencies confirmed a hierarchy of associations with bined by restricting the analysis to five allele groups: DQB1*060x (DQw6); *050x (DQw5); 3a (including DRB1 alleles ranging from strongly positive with DRB1* 1501, through weaker positive with DRB1*04 and DQw8 or *0302, DQw9 or *0303 and DQw4 or *040x); *0301 (DQw7); and *020x (including all DQw2 splits). DRB1*03, neutral or slightly negative with DRB1*01 to strongly negative with DRB1*07. The results were The phenotype frequency of DQB1*060x was higher in patients than controls (OR ϭ 8.7, 95% CI, 5.4 to 14), as remarkably consistent between the series. The only exception was the frequency of DRB1*03, which was sig-expected from the strong linkage disequilibrium between DRB1*1501 and DQB1*0602 ( Fig. 3A) . No other sig-nificantly increased in patients in the combined analysis (reflecting the large number of DRB1*03 alleles in the nificant positive associations were identified, but several apparent negative associations occurred that were possi-patients reported by Huey et al) but indistinguishable from controls in the largest single study. More impor-bly due to the preponderance of DQB1*06 alleles. Therefore, relative predispositional analysis was applied to tantly, an analysis of a larger number of patients provided an opportunity to extend previous studies in three ways: non-DQB1*06 alleles (Fig. 3B ). The analysis detected a positive association with DQ3a alleles (OR ϭ 1.9, 95%
(a) analysis of the relationship between class II structure and disease susceptibility based on the frequencies of CI, 1.3 to 2.7) and a negative association with DQB1*05 alleles. Separate analysis of the two studies that further structurally related alleles, some of which are rare; (b) examination of the frequencies of DRB1 alleles in the distinguished DQ alleles suggested that this association was due to an increased frequency of DQB1*0302 (OR ϭ minority of patients without DRB1*1501; and (c) analy- sis of how susceptibility to the disease is influenced by 160x; thus, to gain an indication of the frequency of these alleles, the 139 patients were analyzed as a single group. inheriting combinations of disease-associated and disease-protective DRB1 alleles to determine whether and Both alleles were rare in all three of the control Caucasoid populations, occurring with estimated frequency of how they interact. approximately 0.007 to 0.008 and 0.008 to 0.011, respectively. DRB1*1502 occurred in 3 of 139 patients, which OCCURRENCE OF STRUCTURALLY RELATED was close to the expected number of 1.9 to 2. DRB1*16 DRB1 ALLELES occurred in none of the 139 patients (expected number Alleles related to DRB1*1501 2.2 to 3), but this result would be expected in as many as 5 to 10% of studies of this size by chance alone. The DRB1*1501 allele encodes the DR␤ chain of an Nevertheless, it is clear that DRB1*16 is not associated HLA class II molecule that carries the DR15 split of the with Goodpasture's disease to the same degree as DR2 specificity. At least 10 other DRB1 alleles encode DRB1*1501. If it were as over-represented among pa-␤ chains of DR molecules carrying the DR2 specificity, tients as B1*1501, it should occur at a frequency of apnamely DRB1*1502 through 1505 and DRB1*1601 proximately 3.5 times that in the control populations, through 1606, but DRB1*1501 is overwhelmingly the and the expected number of DRB1*16 alleles would be most common in North European Caucasoids and ac-6.6 to 9 and the probability of observing 0 out of 139 counts for 90% of these alleles. Analysis of associations would be less than 0.001. The implication of this finding with the DRB1*1502 and DRB1*16 allele should be is discussed later in this article. highly informative because they encode DR molecules that differ only slightly from that encoded by DRB1* Alleles related to DRB1*04 and *03 1501. Thus, any differences could identify features critical for disease susceptibility.
To determine whether the DR4 association with Goodpasture's disease was similarly DR4 subtype specific, the There was insufficient data to undertake meta-analysis of the relevant rarer alleles DRB1*1502 and DRB1* frequency of DR4 subtypes was obtained for the disease and control populations reported by Huey and Fisher patients in the series reported by Dunkley and 3 out of 20 in the series reported by Fisher, giving a significantly (42 DR4 alleles in 103 patients); Dunkley et al did not distinguish DR4 subtypes. As pointed out by Huey et reduced odd ratio for disease in DR15-negative DR7positive individuals (OR ϭ 0.3, 95% CI, 0.1 to 0.7, P ϭ al, the patients they studied had an excess of DRB1*0404 alleles (4 of 8 DR4 alleles, OR 4.7), but this was not 0.004). No other allele, including DR1, occurred significantly less frequently than expected among DR15-nega-present in the larger series of 80 patients described by Fisher (7 out of 34, OR 1.2). The small number of DR4 tive patients. The frequencies of DR4 and DR3 were not consis-alleles did not permit a similar comparison for each of the over 20 DR4 subtypes that are known, but it was tently elevated in DR15-negative patients. The frequency of DR3 alleles was indistinguishable from the possible to compare subtypes grouped by structural features likely to influence peptide-binding preferences [30, DR15-negative control populations (the odds ratios for occurrence of DR3 in the two studies were 0.3 and 0.8), 31]. There was no evidence that the DR4 association favored any particular DR4 subtype, nor subtypes and although most of the DR15-negative patients reported by Dunkley inherited DR4 (12 out of 13, OR 11), grouped by charge at DR␤71 or size at DR␤86. One explanation for this result could be that different DR4 DR4 was inherited by only the expected number of those reported by Fisher (9 out of 20, OR 0.8). alleles influence Goodpasture's disease by different mechanisms. As discussed later in this article, there is some Therefore, the inheritance of DR4 and DR3 is less clearly associated with increased susceptibility to Good-evidence for a different effect of DR4 alleles in the presence and absence of DRB1*1501. A similar analysis was pasture's disease in the absence of DR15, not more strongly as might be expected if DR15, DR4 and DR3 attempted for DR4 subtypes occurring with and without 1501, and no significant subtype association could be influenced disease susceptibility by the same mechanism. Because DR4 and DR3 are frequent among patients identified, albeit among a small number of alleles. The results raise the possibility of a mechanism independent with Goodpasture's disease as a whole but not (or at least not strikingly so) among the subgroup without DR15, it of the structure of the DR4 peptide binding groove, possibly involving a gene in linkage disequilibrium.
appeared that DR4 and DR3 alleles had their major influence only in the presence of DR15. This raises the The preponderance of DRB1*0301 or 0302 alleles did not account for the association with DRB1*03, which question of whether or not DRB1 heterozygosity affected susceptibility to Goodpasture's disease. was, therefore, like the association with DRB1*04 and not subtype specific.
INFLUENCE OF DRB1 HETEROZYGOSITY ON SUSCEPTIBILITY TO GOODPASTURE'S DISEASE HLA DR PHENOTYPE FREQUENCIES IN DR15-NEGATIVE PATIENTS
Defining disease-associations with combinations of alleles inherited at HLA class II loci has been important If DRB1*04 and DRB1*03 alleles increase susceptibility to Goodpasture's disease by the same mechanism as in understanding the HLA associations with diseases including insulin-dependent diabetes mellitus (IDDM) DRB1*1501, then these alleles would be expected to be particularly frequent in the 25% of patients (35 out of [33], rheumatoid arthritis [34], and celiac disease [1] . The possible importance of heterozygosity in Goodpasture's 139) who did not have DRB1*1501. Also, because alleles inherited at DRB1 have such a strong influence on sus-disease was assessed by a three-step approach. First, the frequency of alleles inherited with DRB1* ceptibility to Goodpasture's disease, an analysis of DR15negative patients could detect other associations not 1501 was examined to ascertain whether certain alleles were inherited with DRB1*1501 more frequently than apparent in the presence of the very strong susceptibility factor DRB1*1501. Therefore, the phenotype frequen-in DRB1*1501-bearing control populations. There was a highly significant excess of DR3 and DR4 alleles and cies in the DR15-negative subgroup of the patients were compared with the expected phenotype frequencies deficiency of DR1 and DR7 alleles in patients who also inherited DRB1*1501 ( Fig. 4 ). This confirmed the im-among DR15-negative controls (estimated from the reported allele frequencies assuming Hardy-Weinberg pression that the excess of DR3 and DR4 alleles in Goodpasture patients was in large part because of an excess of equilibrium as described by Lathrop) [32] .
Only the reports by Dunkley and Fisher described DR15, 4/3 heterozygotes, and suggested that the DRB1 allele inherited with DRB1*1501 could modulate the sufficient DR15-negative patients for meaningful analysis (13 and 20, respectively; only 2 of the 23 patients disease susceptibility associated with DRB1*1501. Next, the odds ratios for disease were calculated for reported by Huey did not carry DR15). The reduced frequency of DR7 found among Goodpasture's disease selected DRB1 combinations (Fig. 5 ). The odds ratios for 1501 paired with 1501, 03, or 04 alleles were in the patients as a whole was also found among DR15-negative patients. DR7 was carried by 1 of the 13 DR15-negative range of 6.9 to 7.6, and no distinction could be made between them. The odds ratio for 1501 paired with any but DRB1*01 and DRB1*07 reduce or even abolish that susceptibility. allele except 1501 or 7, the two alleles with strongest influence on disease, was very similar (called 15,Y in Fig. An analysis of the frequencies of DRB1*04 or 03 alleles inherited in the absence of DRB1*1501 produced 5, OR ϭ 6.9). By contrast, the odds ratios for 1501 paired with DR1 or DR7 were not significantly different from odds ratios for disease that were less than 1, even when DR7 containing combinations were removed (DR4,Y unity. Other alleles did not occur with 1501 sufficiently frequently for separate analysis in all studies. DR14 oc-and DR3,Y in Fig. 5 ), but this could have been because of the preponderance of DRB1*1501-containing geno-curred with 1501 in two of the three studies, and when these two studies were combined, the odds ratio for types. Thus, the third step was to analyze the frequency of DRB1*04-and DRB1*03-containing genotypes after disease was 6.4, again indistinguishable from 1501 inherited with 1501, 03, or 04 alleles.
removing non-DRB1*1501-containing genotypes (Fig.  6 ). The frequencies of DR4,4 and DR4,Y allele combina-The results demonstrate that the inheritance of a DRB1*1501 allele at one DRB1 locus confers a height-tions were significantly higher in DR15-negative patients than in DR15-negative control populations, which is con-ened susceptibility to Goodpasture's disease that is little influenced by inheriting a second DRB1*1501 allele. sistent with DRB1*04 being associated with disease independent of the presence of DRB1*1501. However, the There is, therefore, no evidence of a gene dosage effect similar to that reported for the association between frequency of DR3,Y combinations did not differ significantly from controls. The analysis also detected an excess DRB1*0401/4 with rheumatoid arthritis [34] . Alleles including DRB1*03, DRB1*04, and DRB1*14 alleles simi-of DRB1*12 alleles. This allele did not occur with DRB1*1501 in any patient in any of the studies (approxi-larly have no detectable further influence on disease susceptibility over that conferred by DRB1*1501 alone, mately 1.6 would have been expected from the average frequency of DRB1*12 in the control populations, not ways. First and most important, it demonstrated that the significant), but occurred in 5 of 35 DR15-negative pa-HLA B1 alleles inherited at the 2 DRB1 loci interact tients (expected about 1, OR ϭ 5.5, P ϭ 0.001).
in influencing susceptibility to Goodpasture's disease. Therefore, susceptibility to Goodpasture's disease is Thus, the strong increase in the odds ratio for disease influenced by the HLA DRB1 alleles inherited on both associated with inheritance of one DRB1*1501 allele is chromosomes. However, in contrast with results from modulated by the coinherited DRB1 allele in the order patients with severe rheumatoid arthritis [34], the allele 1501,1501 ϳ 1501,4 ϳ 1501,3 ϳ 1501,14 Ͼ 1501,1 Ͼ inherited with the susceptibility allele in Goodpasture's 1501,7. Second, it suggests that the excess of DR4 and disease either had little effect or diminished overall disease DR3 alleles is largely due to their neutral influence in susceptibility; in no instance did it increase susceptibility.
the presence of DR15. Third, it defines DQB1*0302 as This result is reminiscent of the effect of certain DR4 positively associated with the disease. Finally, it defines subtypes in reducing the DQ8-associated susceptibility DR4 and possibly DR12 as associated with susceptibility to IDDM in Danes [33] .
to disease in DR15-negative patients. In summary, the meta-analysis confirmed the previously reported associations of Goodpasture's disease INFERENCES FROM HLA ASSOCIATIONS with DRB1*1501 (and DQB1*0602), and DR4 and nega-Interpreting HLA associations with autoimmune distive association with DR7 and DR1 (and DQB1*0501) and extended these observations in several important ease must proceed via several steps. First, an attempt telomeric to DRA, as class I loci telomeric to DRA show less strong associations with disease [11] . Nor is the locus likely to be far centromeric to DQB1 where recombination events are more frequent. Although the contribution of these alleles to the disease association could not be dissected on the basis of the association data alone, consideration of the structure of the encoded class II molecules strongly implicated DRB1*1501 as the primary susceptibility allele (discussed later in this article).
The association with DR4 is not with any individual DR4 subtype and not even with any class of subtypes with similar peptide binding grooves, and thus, may be a consequence of linkage disequilibrium with another susceptibility locus. One possibility is DQB1*0302, which is also weakly associated with the disease, but this is unlikely because the association with DQB1*0302 (OR ϭ 1.9 after removing DQ6 alleles) is less strong than with DR4 (OR ϭ 2.5 after removing DRB1*1501 alleles). It is equally difficult to explain the association with DR3 on the basis of differences in the shape of the peptide-binding groove, as it affects both of the common DRB1*03 subtypes. As with DR4, there is an association DQB1*0201, but this is not as strong as with DR3. Therefore, the associations with DR4, DR3, and DQB1*0302 probably reflect linkage disequilibrium with loci telomeric to DRB1, such as the TNF loci, which may account is made to distinguish the locus that accounts for the for some DR3 associations in IDDM [36]. association. Second, the structure of the gene products
The negative association with DRB1*07 is not due to of responsible loci is compared with reference to their linkage disequilibrium with DQB1 because it was inherinfluence on disease susceptibility. Third, the functional ited with four different DQB1 alleles in the five patients consequences of differences in structure are analyzed.
in which DQB1 types were distinguished: Two had Finally, the implications for possible mechanisms for the DQB1*02, one had DQB1*0301, one had DQB1*0302, associations can be deduced. and one DR7 homozygote had DQB1*02 and DQB1* 0303. The negative associations with DR1 and DQB1* Distinguishing the loci that account for associations 0501, the DQB1 allele inherited on most DR1 haplowith Goodpasture's disease types, were indistinguishable, but the similarity of the The class II region and adjacent class I and class II structure of DRB1*07 and DRB1*01 suggests the negaregions on chromosome 6 ( Fig. 1 ) are crowded with genes tive association is more likely to be due to DRB1*01 known to influence immune responses [35] . Some are than DQB1*0501 (discussed later in this article). highly polymorphic, and many are in linkage disequilib-Thus, the major positive and negative associations with rium with each other, so it must always be considered DRB1*1501 and with DRB1*07 and DRB1*01, respecthat associations with particular alleles are due to the tively, are probably explained directly by influences of presence of known or unknown polymorphic loci in link-DRB1 genes, whereas the positive associations with DR3 age disequilibrium. Some localization of the loci responand DR4 may be due to genes in linkage disequilibrium. sible for associations is possible because recombination Structure and function of disease-associated in these regions has occurred frequently, and many al-HLA molecules leles occur on more than one haplotype. However, the DRDQ region is only 80 to 300 kb in size, and some It is possible to consider structure and function toalleles effectively occur on single haplotypes preventing gether because the structural basis of class II/peptide this approach.
interactions is well understood [reviewed in 3]. Peptides This is true of DRB1*1501, DRB5*0101, and DQB1* are clasped by class II molecules over a stretch of approx-0602, which effectively always occur together. However, imately 12 amino acids; this core binding sequence lies the locus responsible for the strong associations with in an extended conformation in the (open-at-both-ends) class II peptide-binding groove. Any projecting side DRB1*1501 and DQB1*0602 is unlikely to lie much HLA class II allele  85  86  89  90  13  70  71  74  78  11  13  28  47  61  67  71  9 57 chain residues are accommodated in pockets in the floor alleles all encode positively charged residues (arginine or histidine) at ␤13 and glutamine residues at ␤70, both and walls of the groove. The pockets accommodate side chains 1, 4, 6, 7, and 9 of the bound peptide and are of which flank pocket 4. This combination is unique to these alleles. Indeed, positively charged residues at ␤13 referred to as pockets 1, 4, etc., after the system proposed by Stern and Wiley [37] . Residues encoded by relevant are almost confined to disease-associated alleles, because apart from DRB1*15 and *04 alleles, they only occur in alleles that flank pockets in the class II peptide-binding groove are shown in Tables 3 and 4. DRB1*16 alleles and the rare DRB1*1410. DRB1*04 alleles are no more similar to DRB1*1501 at other pock-Structural comparisons of HLA class II molecules associated with disease can be helpful in at least two ways. ets than many other DRB1 alleles. Interestingly, DRB1* 12 alleles, which may be associated with Goodpasture's First, structural similarities between different HLA molecules associated with a particular disease provide evi-disease in DRB1*15-negative patients, do not share these properties with DRB1*15 and DRB1*04 alleles, so they dence for involvement of the alleles themselves, rather than genes in linkage disequilibrium with them. Struc-may increase susceptibility by a different mechanism. It is notable that the allele with strongest protective tural differences between alleles with contrasting associations are similarly informative. Second, the structural effect, DRB1*07, is different from DRB1*1501 at every polymorphic residue flanking pocket 4. In particular, it features of the class II peptide-binding groove can be used to infer characteristics of peptides that are impor-encodes a bulky aromatic residue (tyrosine) at ␤13, a feature it shares with DRB1*01 alleles and that is unique tant for disease susceptibility. Consideration of the structures of disease-associated DRB1 alleles in Goodpas-to DRB1 alleles associated with protection from Goodpasture's disease. Furthermore, DRB1*07 encodes as-ture's disease allows inferences in both categories.
Goodpasture's disease was originally associated with partic acid at ␤70 as found in DRB1*16. The size of the residues flanking pocket 4 provides a further distinction the HLA DR2 specificity, which is now known to be encoded by the closely related DRB1*15 and *16 alleles.
between disease-associated and protective alleles. Pocket 4 of DR7 is physically much smaller than that of disease-DR15 and DR16 molecules are structurally very similar but have a small number of important differences in associated alleles because all of the polymorphic residues flanking pocket 4 in DRB1*07 are large, whereas 2/5 in residues flanking pockets 4 and 7 of the peptide-binding groove ( Table 3 ). Goodpasture's disease is strongly asso-DRB1*1501 and 1/5 in DRB1*04 are very small. The observation that pocket 4 is the most striking site of ciated with DRB1*1501 and probably as strongly associated with DRB1*1502, but not with DRB1*16 alleles.
differences between disease-associated and protective class II molecules is reminiscent of the findings in rheu-The residues flanking pockets 4 and 7 are identical in DRB1*1501 and 1502 but very different in DRB1*16 matoid arthritis [31, 39] and pemphigus vulgaris [38] . In both of these diseases, the major difference is related to alleles, particularly at the often critical residue ␤71 [31, 33, 38] , which differs markedly in both size and charge.
the charge of pocket 4, whereas in Goodpasture's disease, it appears to relate to charge and size. Therefore, a difference in pockets 4 and 7 distinguishes DR2 alleles associated with Goodpasture's disease from
The correlation between class II structure and the DRB1 alleles associated with Goodpasture's disease ar-those that are not.
A comparison of DRB1 alleles with weaker positive gues strongly that the HLA associations are due to the DRB1 alleles themselves and not genes in linkage dis-and negative associations with disease provide further support for the influence of pocket 4 in susceptibility equilibrium with them. However, DR15 and DR16 alleles are almost invariably inherited with specific DRB5 to Goodpasture's disease. DRB1*1501/2 and DRB1*04 HLA class II allele  85  86  89  90  13  70  71  74  78  11  13  28  47  61  67  71  9  57 Strong positive DRB1*1501
Pocket numbering and flanking residues are taken from Stern et al [58] . DRB5*0101 is expressed on DR15 and DR16 bearing haplotypes and DRB4*0101 on DR7 bearing haplotypes. and DQB1, so it is important to subject them to similar glycine at ␤86 can additionally bind with an approximate tenfold higher affinity peptides with large hydrophobic structural analysis (Fig. 1) . The association could theoretically be due to linkage disequilibrium with DRB5* side chains (such as tryptophan, tyrosine, and phenylalanine). Therefore, DRB1*1501 and 1502 could increase 0101, but this is unlikely because the residues flanking pocket 4 encoded by DRB5*0101 are similar to those of susceptibility by presenting the same peptide about equally well, provided the peptide did not have trypto-the protective alleles DRB1*01 and DRB1*07. In fact, DRB5*0101 differs from DRB1*07 only at position 70 phan, tyrosine, or perhaps phenylalanine at position P1. Because pocket 4 is so clearly influential on disease sus-of the residues flanking pocket 4, and like DRB1*01 and DRB1*07, it encodes an aromatic residue at ␤13. Thus, ceptibility, it is also very relevant to consider the effects of differences in residues flanking this pocket in disease-DRB5*0101 is very unlikely to account for the positive association between Goodpasture's disease and the associated and disease-protective class II molecules. This DRB1*1501, DRB5*0101, DQB1*0602 disease-associis more complex as the several polymorphic residues ated haplotype. The DQB1 alleles in linkage disequilibflanking pocket 4 could interact with each other as well rium with DRB1*1501 and 1502 are very dissimilar, so as with the P4 side chain of a bound peptide. However, a primary association with DQB1*0602 would not acone distinction that is very likely to be influential is the count for the apparently similar strengths of these haplophysical size of the pocket, which is much larger in the types. Therefore, the structure of disease-associated al-DR15 molecule than the DR1 and very likely the DR7 leles strongly suggests that Goodpasture's disease is molecule [40] . This could allow DR15 to bind much more associated with DRB1*1501 itself and that susceptibility efficiently than DR1/7 to peptides with large residues is in some way related to the peptide-binding characterissuch as tryptophan at P4. tics of the DR15 molecule it encodes.
The association with DR4 probably reflects more Structural comparisons also suggest that some characthan one mechanism teristics of the peptides DR15 might present to influence disease susceptibility. DRB1*1501 and 1502 differ only
The association with DR4 is complex, as the allele appears to influence disease susceptibility both through in having valine and glycine, respectively, at position ␤86 flanking pocket 1. Because this difference does not its neutral influence in the presence of DRB1*1501 and by a positive influence apparent when it occurs in the greatly influence disease susceptibility, it is interesting to examine the likely influence on peptide-binding pref-absence of DRB1*1501. If these effects are consequences of the structure of the encoded DR molecules and their erences. DR molecules with valine at ␤86 can bind peptides with medium-sized hydrophobic side chains at posi-peptide-binding characteristics, it would be expected that the disease association with DR4 would be strongest tion P1 (such as valine, isoleucine, leucine, methionine, and perhaps phenylalanine), whereas DR molecules with with specific DR4 subtypes, as has been shown for type I diabetes mellitus [33] and rheumatoid arthritis [41] . For peptides displayed most abundantly on the surface of DR15 APCs in vivo. However, an analysis of the binding example, rheumatoid arthritis is associated with DR4 alleles encoding positively charged residues at DR␤71 of a set of overlapping peptides spanning the sequence of ␣3(IV)NC1 showed that peptides representing almost (which flanks pocket 4 of the peptide binding groove), which has the effect of favoring the binding of peptides two thirds of the sequences of the antigen had affinity as good or better than those known to be presented able to lodge a negatively charged side chain in pocket 4 [30, 31] .
at high level (Fig. 7) . These data show that ␣3(IV)NC1 contains numerous peptides able to bind DR15 that could None of the DR4 subtypes accounted for the DR4 association with Goodpasture's disease, even when sub-be productively recognized by autoreactive T cells, but only three that appear to be constitutively displayed to types were grouped by structure/function, and there are at least four ways in which this can be explained. First, T cells, at least under the experimental conditions. These are the peptides to which tolerance is most likely to be the DR4 association could be a due to peptide-binding characteristics shared by the common DR4 alleles, but securely established, unless ␣3(IV)NC1 is hidden from the immune system, which is improbable given its expres-this is unlikely. The alleles vary markedly at residues flanking pockets 1 (␤86), 4 (␤71 and 74), and 7 (␤28 and sion in several tissues and occasional detection in the urine [44] . Tolerance is much less likely to be established 47), and these variations are known to have a marked influence on the binding of peptides with bulky aromatic to the other ␣3(IV)NC1 peptides, so there is considerable scope for the development of autoimmunity to residues at position P1 or charged residues at P4 [30, 31, 42] . Second, DR4 subtypes could share an association ␣3(IV)NC1. Candidate targets of autoimmune attack under this hypothesis are peptides with high affinity for with a common gene in linkage disequilibrium. Third, DR4 bearing haplotypes could influence disease suscep-DR15, which are not constitutively displayed at a sufficient level to have induced (or maintained) tolerance. tibility by more than one mechanism, and this may have Potentially, these could be presented very efficiently if obscured associations with specific subtypes. Finally, it antigen processing was perturbed, and experiments to is possible the number of DRB1*04 alleles was simply test this hypothesis are currently being performed. insufficient for a subtype specificity to be detected.
By poor presentation of ␣3(IV)NC1 peptides to PEPTIDE-BINDING CHARACTERISTICS OF autoreactive T cells CLASS II MOLECULES COULD INFLUENCE
Poor presentation of certain ␣3(IV)NC1 peptides SUSCEPTIBILITY TO GOODPASTURE'S DISEASE by specific class II molecules might fail to tolerize The structures of class II molecules encoded by DRB1 ␣3(IV)NC1-reactive T cells efficiently yet be sufficient, alleles associated with Goodpasture's disease strongly under certain circumstances, to stimulate T-cell responses, suggest that they influence susceptibility because of the thus creating the potential for autoimmunity. There is characteristics with which they bind autoantigen-derived strong evidence that this mechanism is responsible for peptides. This hypothesis is susceptible to analysis bedisease in some rodent models of autoimmunity [45] , cause the autoantigen ␣3(IV)NC1 has only 230 amino but it is hard to see how it could account for the highly acids. There are at least four ways they could do this.
allele-specific associations seen in Goodpasture's disease. Class II peptide binding is largely stabilized by By efficient presentation of ␣3(IV)NC1 peptides to interactions between conserved residues flanking the autoreactive T cells class II peptide-binding groove and atoms of the peptide DR15 molecules could bind certain ␣3(IV)NC1 pepbackbone of the bound peptide. All peptides have a tides particularly well and thus present them to autoreacpeptide backbone, but stable binding is possible only if tive T cells with unique efficiency. This is how class II a peptide can adopt the necessary extended conformamolecules enhance immune responses to exogenous antition in the peptide-binding groove. This conformation gens such as hen egg lysozyme [43] and probably to orients certain peptide side chain residues into pockets antigens produced by pathogens [2] .
in the floor and walls of the peptide-binding groove, If this is the case, it is possible to speculate on the forcing interactions with residues of the class II molecule probable targets of autoimmune attack because both the that flank the pockets, and these interactions can ennatural presentation of ␣3(IV)NC1 by DR15 APCs [20] hance or impede peptide binding. Consequently, class II and the binding preferences of DR15 molecules for molecules bind many peptides fairly well, some peptides ␣3(IV)NC1-derived peptides are known [21] . When very well, and some not at all. Thus, although one can tested experimentally, DR15 homozygous human B cells easily conceive of class II molecules with a unique ability pulsed with ␣3(IV)NC1 were shown to present three or inability to bind certain peptides, it is difficult to envisnested sets of ␣3(IV)NC1-derived peptides to T cells age a class II molecule that is unique among class II molecules in binding a particular peptide with low affin-[20, 21], and these are very likely to be the ␣3(IV)NC1 . Peptides overlapping naturally processed sequences are labeled with the four residues predicted to lie in positions P1 to P4. All have good affinity for both DR15 molecules, but less than many other peptides that are not detectably presented at the cell surface, presumably because of processing constraints [21] . The affinity of synthetic peptides with sequences identical to naturally processed sequences was generally similar; the most extreme difference was for a short peptide overlapping P17, which had significantly higher affinity than P17 (indicated by arrow), presumably because of fewer adverse interactions outside the peptide-binding groove.
ity. Nevertheless, candidate targets of autoimmune at-Protective class II molecules could delete ␣3(IV)NC1-reactive T cells tack under this mechanism are epitopes in the ␣3(IV) NC1 peptides P2, 3a, 5, 13, 21, and 23 ( Fig. 7) .
DR7 could restrict presentation of a self-peptide that Neutral associations with HLA alleles are simply exdeletes ␣3(IV)NC1-reactive T cells, as has been demonplainable in terms of failure to bind certain self-peptides, strated for mouse class II molecules conferring dominant but neither of the mechanisms discussed so far would protection from diabetes in NOD mice [50] . In that explain the protective effects seen for DR7 and DR1. model, a wide range of class II molecules including I-A b Furthermore, the hierarchy of protection associated with and I-A k ϩ I-E k is able to drive deletion of an I-A g7alleles inherited with DRB1*1501 and particularly the restricted T cell receptor (TCR). Whether a human strong dominant protective influence of DR7 requires DR15-restricted T cell could similarly interact with other other mechanisms. Similar observations have been made class II molecules, such as DR7, and be deleted is far in experimental models of autoimmunity. For example, from clear, as the NOD mouse may be a poor model of class II alleles inherited with susceptibility alleles can human autoimmunity. Certainly DR7 molecules are able exert permissive or protective effects in experimental to bind almost all of the ␣3(IV)NC1 peptides we have allergic encephalomyelitis in rats [46] and diabetes in tested with higher affinity than DRA/DRB1*1501 (our NOD mice [47, 48] . In some cases, protection has been unpublished data). shown to correlate with the capacity to bind particular Protective class II molecules could sequester peptides [49] . The similarity of the DR1 and DR7 pep-␣3(IV)NC1 peptides tide-binding grooves argues that a similar mechanism might also operate to protect from Goodpasture's dis-An alternative mechanism is the capture hypothesis proposed by Nepom to account for protection from ease. If so, this could be explained in a least two ways. DR7 or DR1 than to DR15 (manuscript in preparation). Therefore, this mechanism could account for the protection seen in Goodpasture's disease, provided the peptides recognized by patients' autoreactive T cells are included in this subgroup. The specificity of patients' autoreactive T cells is not known, but our data suggest that competition could be relevant for the majority of ␣3(IV)NC1 peptides, including all of those known to be naturally processed.
CONCLUSION
The power of meta-analysis has advanced knowledge of the HLA association with Goodpasture's disease in several important ways. First, although naturally confirming the strong association with DRB1*1501, the study has additionally clarified the association with other alleles that had been inconstantly reported in the individ- ization of the susceptibility-enhancing effect of DRB1* two identical peptide fragments bound using slightly different but overlapping core-binding sequences to two different class II molecules in a 1501 by coinherited DRB1*07. These observations schematic peptide-binding compartment. Were this fragment the natustrongly suggest an interaction, most likely occurring rally processed LEEF sequence of ␣3(IV)NC1 and the class II molecules between the class II molecules they encode. Third, we DRA/DRB1*1501 and DR7, then the vastly greater binding affinity of DR7 would be expected to sequester this peptide, preventing its display have been able to assess the occurrence of rarer subtypes bound to DR15, even though the LEEF peptide is one of the major of disease-associated alleles to deduce some of the struc-␣3(IV)NC1 peptides presented bound to DR15 by DR15 homozygous tural features that correlate with positive and negative APC.
associations.
The findings for Goodpasture's disease are in many ways similar to those reported for other autoimmune IDDM in which protective class II molecules "steal" diseases. The great value of Goodpasture's disease as a peptide (by virtue of having greater affinity) from those model of human autoimmunity is seen in the way the conferring susceptibility [51]. The ability of coexpressed epidemiological data can be used to infer peptides that class II molecules to influence the peptides each displays may be relevant in the disease, generating hypotheses has been demonstrated, again in the NOD mouse ( Fig. to explain HLA associations with autoimmunity that are 8) [52] . It is notable that in Goodpasture's disease, the accessible to experimental validation. For example, the protective class II molecules DR7 and DR1 have a very concept of determinant capture by protective class II high affinity for many ␣3(IV)NC1 peptides and thus have molecules can now be tested by comparing the affinity of the potential to limit their presentation bound to DR15 ␣3(IV)NC1 peptides to disease-associated and diseaseunless the sequestration mechanism was disrupted. This protective class II molecules and by comparing the could occur as a consequence of an increased load of ␣3(IV)NC1 peptides displayed bound to DR15 mole-␣3(IV)NC1, perhaps following renal injury, or because cules by DR15 homozygous and DR15, 7 heterozygous of displacement by other peptides with an even higher antigen-presenting cells (APC). These studies have the affinity. Candidates would be microbe-derived peptides, power to define mechanisms that could be relevant to and it is notable that both renal injury and infection have other renal diseases with strong HLA associations [rebeen proposed as possible triggers of Goodpasture's disviewed in 55], such as idiopathic membranous nephropaease [53, 54] .
thy and childhood steroid-responsive nephrotic syn-We have compared the capacity of DR1, DR7, and drome, as well as autoimmune diseases affecting other DR15 to bind a set of overlapping peptides and found organs, for example, rheumatoid arthritis and IDDM. In addition to helping to understand HLA associations a large subgroup with a substantially higher affinity for
